These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 15533930)
1. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. Nagai T; Abe A; Sasakawa C J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930 [TBL] [Abstract][Full Text] [Related]
2. The EspF N-Terminal of Enterohemorrhagic Wang X; Du Y; Hua Y; Fu M; Niu C; Zhang B; Zhao W; Zhang Q; Wan C Front Cell Infect Microbiol; 2017; 7():410. PubMed ID: 28983470 [TBL] [Abstract][Full Text] [Related]
3. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals. Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784 [TBL] [Abstract][Full Text] [Related]
4. The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7. Zhao S; Zhou Y; Wang C; Yang Y; Wu X; Wei Y; Zhu L; Zhao W; Zhang Q; Wan C PLoS One; 2013; 8(1):e55164. PubMed ID: 23372831 [TBL] [Abstract][Full Text] [Related]
5. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Nougayrède JP; Donnenberg MS Cell Microbiol; 2004 Nov; 6(11):1097-111. PubMed ID: 15469437 [TBL] [Abstract][Full Text] [Related]
6. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531 [TBL] [Abstract][Full Text] [Related]
8. The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology. Papatheodorou P; Domańska G; Oxle M; Mathieu J; Selchow O; Kenny B; Rassow J Cell Microbiol; 2006 Apr; 8(4):677-89. PubMed ID: 16548893 [TBL] [Abstract][Full Text] [Related]
9. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction. Dean P; Scott JA; Knox AA; Quitard S; Watkins NJ; Kenny B PLoS Pathog; 2010 Jun; 6(6):e1000961. PubMed ID: 20585567 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells. Tahoun A; Siszler G; Spears K; McAteer S; Tree J; Paxton E; Gillespie TL; Martinez-Argudo I; Jepson MA; Shaw DJ; Koegl M; Haas J; Gally DL; Mahajan A Infect Immun; 2011 Nov; 79(11):4716-29. PubMed ID: 21875965 [TBL] [Abstract][Full Text] [Related]
11. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Nougayrède JP; Foster GH; Donnenberg MS Cell Microbiol; 2007 Mar; 9(3):680-93. PubMed ID: 17064289 [TBL] [Abstract][Full Text] [Related]
12. The EspF effector, a bacterial pathogen's Swiss army knife. Holmes A; Mühlen S; Roe AJ; Dean P Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436 [TBL] [Abstract][Full Text] [Related]
15. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426 [TBL] [Abstract][Full Text] [Related]
16. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425 [TBL] [Abstract][Full Text] [Related]
17. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. Alto NM; Weflen AW; Rardin MJ; Yarar D; Lazar CS; Tonikian R; Koller A; Taylor SS; Boone C; Sidhu SS; Schmid SL; Hecht GA; Dixon JE J Cell Biol; 2007 Sep; 178(7):1265-78. PubMed ID: 17893247 [TBL] [Abstract][Full Text] [Related]
18. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Dean P; Kenny B Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358 [TBL] [Abstract][Full Text] [Related]
19. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Quitard S; Dean P; Maresca M; Kenny B Cell Microbiol; 2006 Jun; 8(6):972-81. PubMed ID: 16681838 [TBL] [Abstract][Full Text] [Related]